Avidity Biosciences (RNA)

• Market cap: $10.9B
• 1 day: -0.12%
• 5 days: 0.3%
• 1 month: 0.75%
• 3 months: 48.65%
• 6 months: 116.25%
• Year to date: 0.57%
• 1 year: 156.31%
• 5 years: 164.06%
• 10 years: 154.42%
• Sector: Healthcare
• Industry: Biotechnology

About: Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Employees: 391